Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 411 publications
Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.
Journal: Leukemia & lymphoma
Published: July 17, 2026
Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.
Journal: JCO oncology practice
Published: June 01, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).
Journal: Lancet regional health. Americas
Published: March 25, 2026
Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.
Journal: Blood
Published: March 13, 2026
Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study.
Journal: Advances in therapy
Published: February 07, 2026
Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia.
Journal: Leukemia & lymphoma
Published: January 05, 2026
Measure What Matters: Rethinking Surrogate Metrics of Success in Radiation Oncology.
Journal: International journal of radiation oncology, biology, physics
Published: November 05, 2025
Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis.
Journal: Cancer medicine
Published: September 11, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.
Journal: Haematologica
Published: July 09, 2025
Last Updated: 09/26/2026